Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aropax
2. Brl 29060
3. Brl-29060
4. Brl29060
5. Fg 7051
6. Fg-7051
7. Fg7051
8. Paroxetine
9. Paroxetine Hydrochloride
10. Paroxetine Hydrochloride Anhydrous
11. Paroxetine Hydrochloride Hemihydrate
12. Paroxetine Hydrochloride, Hemihydrate
13. Paroxetine Maleate
14. Paroxetine, Cis-(+)-isomer
15. Paroxetine, Cis-(-)-isomer
16. Paroxetine, Trans-(+)-isomer
17. Paxil
18. Seroxat
1. 72471-80-8
2. Ypo0ntk49o
3. Acetic Acid;(3s,4r)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
4. Unii-ypo0ntk49o
5. Schembl4200728
6. Dtxsid70222772
7. Paroxetine Acetate [who-dd]
8. Q27294647
9. Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3s-trans)-, Acetate
10. Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, Acetate (1:1), (3s,4r)-
| Molecular Weight | 389.4 g/mol |
|---|---|
| Molecular Formula | C21H24FNO5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 389.16385103 g/mol |
| Monoisotopic Mass | 389.16385103 g/mol |
| Topological Polar Surface Area | 77 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 433 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
Cytochrome P-450 CYP2D6 Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6. (See all compounds classified as Cytochrome P-450 CYP2D6 Inhibitors.)
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
ABOUT THIS PAGE
A Ypo0Ntk49O manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ypo0Ntk49O, including repackagers and relabelers. The FDA regulates Ypo0Ntk49O manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ypo0Ntk49O API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ypo0Ntk49O supplier is an individual or a company that provides Ypo0Ntk49O active pharmaceutical ingredient (API) or Ypo0Ntk49O finished formulations upon request. The Ypo0Ntk49O suppliers may include Ypo0Ntk49O API manufacturers, exporters, distributors and traders.
click here to find a list of Ypo0Ntk49O suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ypo0Ntk49O DMF (Drug Master File) is a document detailing the whole manufacturing process of Ypo0Ntk49O active pharmaceutical ingredient (API) in detail. Different forms of Ypo0Ntk49O DMFs exist exist since differing nations have different regulations, such as Ypo0Ntk49O USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ypo0Ntk49O DMF submitted to regulatory agencies in the US is known as a USDMF. Ypo0Ntk49O USDMF includes data on Ypo0Ntk49O's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ypo0Ntk49O USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ypo0Ntk49O suppliers with USDMF on PharmaCompass.
Ypo0Ntk49O Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ypo0Ntk49O GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ypo0Ntk49O GMP manufacturer or Ypo0Ntk49O GMP API supplier for your needs.
A Ypo0Ntk49O CoA (Certificate of Analysis) is a formal document that attests to Ypo0Ntk49O's compliance with Ypo0Ntk49O specifications and serves as a tool for batch-level quality control.
Ypo0Ntk49O CoA mostly includes findings from lab analyses of a specific batch. For each Ypo0Ntk49O CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ypo0Ntk49O may be tested according to a variety of international standards, such as European Pharmacopoeia (Ypo0Ntk49O EP), Ypo0Ntk49O JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ypo0Ntk49O USP).
LOOKING FOR A SUPPLIER?
